Board Meeting Announcement
A meeting of the Board of Directors of the Company is scheduled to be held on Friday, 30 October 2026. The primary purpose of the meeting is to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended 30 September 2026.
Trading Window Closure
The Trading Window for dealing in the securities of the Company has been closed with effect from Thursday, 1 October 2026, in accordance with the company's previous communication dated 25 September 2026. The Trading Window shall remain closed until 48 hours after the declaration of the financial results, specifically up to and including Sunday, 1 November 2026.
Compliance and Signatory
The disclosure is signed by Anoop Deshpande, Company Secretary and Compliance Officer (ICSI Membership No.: A23983), on 14 October 2026 at 20:05:04 +05'30'.
Stock Exchange Information
The company is listed on both National Stock Exchange of India Limited (NSE Code: SUNPHARMA) and BSE Limited (Stock Code: 524715).